The role of thrombin in preterm parturition.

OBJECTIVE Previous reports from our laboratory have shown that thrombin is a potent uterotonic agonist; those studies have suggested a role for thrombin during parturition, especially with regard to intrauterine bleeding. Thrombin activation can be quantified in peripheral blood by measurement of thrombin-antithrombin III (TAT) complex levels. This study sought to determine whether thrombin activation, as measured by thrombin-antithrombin III levels, is associated with premature labor. STUDY DESIGN Thrombin-antithrombin III levels were measured in patients and control subjects with preterm labor. Quantitative TAT levels were determined by use of an enzyme-linked immunoassay with a working range from 0 to 60 ng/mL. All patients were monitored for pregnancy outcome. Receiver operating curve analysis was performed to determine the optimal TAT cutoff values. Further statistical analyses with one-way ANOVA, the chi2 test, or the Fisher exact test were performed to determine statistical significance (P <.05). RESULTS Patients admitted with preterm labor who were subsequently delivered within 3 weeks had significantly higher mean TAT levels (7.80 +/- 2.86 ng/mL; P <.05) than control subjects (5.77 +/- 1.43 mL) or patients with preterm labor who were not delivered within 3 weeks of presentation with preterm labor (5.57 +/- 1.69 ng/mL; P <.05). Given a diagnosis of preterm labor, a TAT level of 8.0 ng/mL had a positive predictive value of 80% for delivery within 3 weeks of enrollment. CONCLUSIONS This study showed that TAT levels are elevated in patients with preterm labor who are destined to deliver before term. These results suggest that preterm labor resulting in premature delivery is associated with the activation of thrombin. Future studies will further elucidate the role of thrombin in preterm parturition and confirm whether tests for thrombin activation can accurately identify those patients destined for preterm delivery.

[1]  T. Terao,et al.  Coagulation/Fibrinolysis Disorder in Patients with Severe Preeclampsia , 1999, Seminars in thrombosis and hemostasis.

[2]  M A Morgan,et al.  Prediction of delivery among women with early preterm labor by means of clinical characteristics alone. , 1999, American journal of obstetrics and gynecology.

[3]  C. Coe,et al.  Antenatal Steroid Treatment and Adverse Fetal Effects: What Is the Evidence? , 2000, The Journal of the Society for Gynecologic Investigation: JSGI.

[4]  G. Haugen,et al.  Markers of intravascular coagulation and fibrinolysis in preeclampsia: association with intrauterine growth retardation , 1997, Acta obstetricia et gynecologica Scandinavica.

[5]  M. Uszýnski.  Generation of thrombin in blood plasma of non-pregnant and pregnant women studied through concentration of thrombin-antithrombin III complexes. , 1997, European journal of obstetrics, gynecology, and reproductive biology.

[6]  M. Bracken,et al.  A systematic review and meta-analysis of prospective studies on the association between maternal cigarette smoking and preterm delivery. , 2000, American journal of obstetrics and gynecology.

[7]  U. Abildgaard,et al.  Thrombin-inhibitor complexes in the blood during and after delivery. , 1996, Thrombosis research.

[8]  D A Savitz,et al.  Risk Factors for Preterm Birth Subtypes , 1998, Epidemiology.

[9]  M. Elovitz,et al.  Effects of thrombin on myometrial contractions in vitro and in vivo. , 2000, American journal of obstetrics and gynecology.

[10]  E. Hodnett,et al.  Tocolytics for preterm labor: a systematic review. , 1999, Obstetrics and gynecology.

[11]  T. Nakamura,et al.  The influence of labor on thrombotic and fibrinolytic systems. , 1992, European journal of obstetrics, gynecology, and reproductive biology.

[12]  M. Oehler,et al.  Risk factors associated with preterm (<37+0 weeks) and early preterm birth (<32+0 weeks): univariate and multivariate analysis of 106 345 singleton births from the 1994 statewide perinatal survey of Bavaria. , 1998, European journal of obstetrics, gynecology, and reproductive biology.

[13]  M. Morgan,et al.  Predicting delivery within 48 hours in women treated with parenteral tocolysis. , 1999, Obstetrics and gynecology.

[14]  K. Salvesen,et al.  Smoking during pregnancy increases the risk of preterm births among parous women , 2000, Acta obstetricia et gynecologica Scandinavica.

[15]  E. Carreras,et al.  Coagulation and Fibrinolytic Parameters in Normal Pregnancy and in Pregnancy Complicated by Intrauterine Growth Retardation , 1998, American journal of perinatology.

[16]  A. Kaider,et al.  Prospective Evaluation of Hemostatic System Activation and Thrombin Potential in Healthy Pregnant Women with and without Factor V Leiden , 1999, Thrombosis and Haemostasis.

[17]  M. Dombrowski,et al.  The preterm prediction study: quantitative fetal fibronectin values and the prediction of spontaneous preterm birth. The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. , 2000, American journal of obstetrics and gynecology.

[18]  J. T. ten Cate,et al.  Laboratory and clinical evaluation of an assay of thrombin-antithrombin III complexes in plasma. , 1988, Clinical chemistry.

[19]  M. Elovitz,et al.  The mechanisms underlying the stimulatory effects of thrombin on myometrial smooth muscle. , 2000, American journal of obstetrics and gynecology.

[20]  H. Pelzer,et al.  Determination of Human Thrombin-Antithrombin III Complex in Plasma with an Enzyme-Linked Immunosorbent Assay , 1988, Thrombosis and Haemostasis.

[21]  Shigenori Suzuki,et al.  Platelet Hemostatic Capacity (PHC) and Fibrinolytic Inhibitors during Pregnancy , 1998, Seminars in thrombosis and hemostasis.